Search

everythinglearnresearchcommunity

for

Search:↓

Breast cancer survivors often face body image and sexual health issues, needing ongoing support and open communication with healthcare providers.

The treatment combining docetaxel, cisplatin, and 5-FU is feasible and effective for advanced head and neck cancer.

Chemotherapy caused nail grooves and separation, but they healed after treatment stopped.

The conclusion suggests that focusing on certain cellular pathways may improve the prevention and repair of hair loss caused by radiotherapy.

Bicalutamide mesotherapy improved hair density in women with hair loss and was well received.

Mohs micrographic surgery is effective for treating basal cell carcinoma on the eyelid, while radiotherapy has higher recurrence rates, and topical vitamin D3 may reduce and delay BCC formation in mice.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

A scalp-cooling system effectively prevents hair loss in breast cancer patients treated with eribulin.

Nurses are exposed to chemotherapy drugs, risking health issues like hair loss, so protective gear and monitoring are needed.

Gemcitabine and paclitaxel are effective and safe as first-line treatment for metastatic breast cancer.

Some breast cancer patients still experience hair loss three years after chemotherapy, especially with taxane-based treatments.

Bortezomib chemotherapy can cause temporary skin rashes.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Breast cancer patients should balance treatment with safe wellness practices to improve quality of life, consulting their oncologist first.

Cyproterone acetate is a safe treatment that causes modest feminization in transgender female adolescents, and works better with added estrogens.

Docetaxel and paclitaxel for breast cancer can cause permanent, severe hair loss.

Permanent eyebrow correction can improve quality of life for those with eyebrow loss.

Combining medication and minimally invasive techniques can effectively manage Marine-Lenhart syndrome.

Some breast cancer patients on hormone therapy experience hair loss, and treatments like certain topical inhibitors and supplements may help without harming their cancer prognosis.

Boosting certain cell signals can prevent hair loss from chemotherapy and radiation.

Boosting certain cell signals can prevent hair loss from chemotherapy and radiation.

Breast cancer hormone therapy can cause hair loss, which can be treated with daily applications of specific topical solutions like minoxidil and hydrocortisone butyrate.

Scalp cooling does not stop hair loss from radiotherapy.

Combining hair transplantation with PRP is more effective for treating hair loss than hair transplantation alone.

Intralesional therapy for keratoacanthoma is effective and has fewer side effects than systemic treatments.

Bicalutamide mesotherapy may help with hair loss and seborrhea but needs more research.

Activating certain cells in hair follicles can prevent hair loss caused by cancer treatments.

Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.

Prostaglandin E2 helps prevent hair loss from radiotherapy by protecting hair growth cells and aiding self-repair.

Erlotinib can cause hair loss and texture changes.